Nagendu Dev
5Patents
5h-index
7Co-inventors
48Inventor score
Filing activity: Jun 24, 1996 → Oct 1, 2001
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5944710A | Electroporation-mediated intravascular delivery | Emerging Cross-Sectional Technologies | 411 | Expired |
| US6347247B1 | Electrically induced vessel vasodilation | Emerging Cross-Sectional Technologies | 313 | Expired |
| US6865416B2 | Electrically induced vessel vasodilation | Emerging Cross-Sectional Technologies | 308 | Expired |
| US6654636B1 | Skin and muscle-targeted gene therapy by pulsed electrical field | Human Necessities | 252 | Expired |
| US6697669B2 | Skin and muscle-targeted gene therapy by pulsed electrical field | Human Necessities | 182 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.